Cargando…
DYRK2 downregulation in colorectal cancer leads to epithelial–mesenchymal transition induction and chemoresistance
Colorectal cancer (CRC) is among the most prominent causes of cancer-associated mortality in the world, with chemoresistance representing one of the leading causes of treatment failure. However, the mechanisms governing such chemoresistance remain incompletely understood. In this study, the role of...
Autores principales: | Wu, Chunrong, Sun, Guiyin, Wang, Fan, Chen, Jiangyan, Zhan, Fangbiao, Lian, Xiaojuan, Wang, Jie, Weng, Fanbin, Li, Bo, Tang, Weijun, Quan, Jin, Xiang, Debing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797492/ https://www.ncbi.nlm.nih.gov/pubmed/36577753 http://dx.doi.org/10.1038/s41598-022-25053-0 |
Ejemplares similares
-
ECM1 regulates the resistance of colorectal cancer to 5-FU treatment by modulating apoptotic cell death and epithelial-mesenchymal transition induction
por: Long, Sirui, et al.
Publicado: (2022) -
Extracellular Matrix Protein 1 Regulates Colorectal Cancer Cell Proliferative, Migratory, Invasive and Epithelial-Mesenchymal Transition Activities Through the PI3K/AKT/GSK3β/Snail Signaling Axis
por: Long, Sirui, et al.
Publicado: (2022) -
DDX49 is a novel biomarker and therapeutic target for lung cancer metastases
por: Lian, Xiaojuan, et al.
Publicado: (2019) -
Tumor Suppressor DYRK1A Effects on Proliferation and Chemoresistance of AML Cells by Downregulating c-Myc
por: Liu, Qiang, et al.
Publicado: (2014) -
Efficacy and safety of iodine-125 brachytherapy combined with chemotherapy in the treatment of advanced NSCLC in the elderly
por: Wu, Chunrong, et al.
Publicado: (2018)